An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

PEI-SHAN YANGChen, Chien-LunChien-LunChenHou, Chen-PangChen-PangHouLin, Yu-HsiangYu-HsiangLinTsui, Ke-HungKe-HungTsui2023-08-312023-08-31201811769092https://scholars.lib.ntu.edu.tw/handle/123456789/634821The aim of this study was to investigate the efficacy and tolerability of switching from 0.2 mg tamsulosin to 0.4 mg tamsulosin oral controlled absorption system (OCAS) over a 12-week period in Taiwanese men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).enLUTS; neoplasms; outcomes; prostate; α1-adrenergic receptorAn open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosinjournal article10.2147/CIA.S152701294452692-s2.0-85041862901https://api.elsevier.com/content/abstract/scopus_id/85041862901